Antiviral Activity of Tumor Necrosis Factor (TNF) Is Mediated via p55 and p75 TNF Receptors
Authors:
Open Access
- 3 November 1997
- journal article
- Published by Rockefeller University Press in Journal of Experimental Medicine
- Vol. 186 (9) , 1591-1596
Abstract
The antiviral nature of tumor necrosis factor (TNF) is generally well accepted. TNF appears to induce multiple antiviral mechanisms, and to synergize with interferon (IFN)-γ in promoting antiviral activities. We infected TNF receptor (TNFR)-deficient mice with the virulent murine pathogen, ectromelia virus (EV), and observed that otherwise resistant mice were susceptible to lethal infection. To study the molecular basis of the antiviral action of TNF, mice were infected with a recombinant vaccinia virus encoding murine TNF (VV-HA-TNF). In normal mice, the replication of VV-HA-TNF was highly attenuated. In contrast, mice in which the TNFR type 1 (p55) or the TNFR type 2 (p75) were genetically disrupted showed a moderate defect in their capacity to clear the TNF-encoding virus. The contribution of both TNF receptors to the control of VV-HA-TNF was confirmed by the enhanced replication of VV-HA-TNF in mice deficient for both p55 and p75. These observations were corroborated by infecting TNFR-deficient mice with EV. For both infections, the p55 and p75 TNFRs were necessary to maintain normal levels of resistance. Thus, the antiviral activity of TNF is mediated via both TNFRs in vivo. Furthermore, these studies establish that TNF is an important component of the host response to a natural virus infection.Keywords
This publication has 38 references indexed in Scilit:
- Role of Lymphotoxin and the Type I TNF Receptor in the Formation of Germinal CentersScience, 1996
- Induction of apoptosis in mature T cells by tumour necrosis factorNature, 1995
- Monoclonal antibodies specific for murine p55 and p75 tumor necrosis factor receptors: identification of a novel in vivo role for p75.Journal of Experimental Medicine, 1995
- Adenovirus genes that modulate the sensitivity of virus‐infected cells to lysis by TNFJournal of Cellular Biochemistry, 1993
- Effects of tumor necrosis factor-α treatment on mortality in murine cytomegalovirus-infected miceAntiviral Research, 1993
- Mice lacking the tumour necrosis factor receptor 1 are resistant to IMF-mediated toxicity but highly susceptible to infection by Listeria monocytogenesNature, 1993
- T2 open reading frame from the shope fibroma virus encodes a soluble form of the TNF receptorBiochemical and Biophysical Research Communications, 1991
- Treatment with anti-tumor necrosis factor α does not influence the immune pathological response against lymphocytic choriomeningitis virusCytokine, 1990
- Tumour necrosis factors α and β inhibit virus replication and synergize with interferonsNature, 1986
- Antiviral effects of recombinant tumour necrosis factor in vitroNature, 1986